郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Adaptive and pathological inhibition of neuroplasticity associated with circadian rhythms and sleep.

期刊:Behavioral neuroscience发表年份:2014作者:H Craig Heller; Norman F Ruby; Asya Rolls; Megha Makam; Damien Colas

药效评价[In vitro safety evaluation of nanomaterials--cellular response to metal oxide nanoparticles].

期刊:Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan发表年份:2014作者:Kazuo Isama

药效评价Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists.

期刊:Archives of pharmacal research发表年份:2014作者:Yu-Juan Zhang; Liu-Lan Shen; Hyae-Gyeong Cheon; Yong-Nan Xu; Jin-Hyun Jeong

药效评价ADN-1184 a monoaminergic ligand with 5-HT(6/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility.

期刊:British journal of pharmacology发表年份:2014作者:M Kołaczkowski; P Mierzejewski; P Bieńkowski; A Wesołowska; A Newman-Tancredi